Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery
Top Cited Papers
- 28 October 2007
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 25 (11) , 1298-1306
- https://doi.org/10.1038/nbt1353
Abstract
Achieving the full potential of zinc-finger nucleases (ZFNs) for genome engineering in human cells requires their efficient delivery to the relevant cell types. Here we exploited the infectivity of integrase-defective lentiviral vectors (IDLV) to express ZFNs and provide the template DNA for gene correction in different cell types. IDLV-mediated delivery supported high rates (13–39%) of editing at the IL-2 receptor common γ-chain gene (IL2RG) across different cell types. IDLVs also mediated site-specific gene addition by a process that required ZFN cleavage and homologous template DNA, thus establishing a platform that can target the insertion of transgenes into a predetermined genomic site. Using IDLV delivery and ZFNs targeting distinct loci, we observed high levels of gene addition (up to 50%) in a panel of human cell lines, as well as human embryonic stem cells (5%), allowing rapid, selection-free isolation of clonogenic cells with the desired genetic modification.Keywords
This publication has 56 references indexed in Scilit:
- An improved zinc-finger nuclease architecture for highly specific genome editingNature Biotechnology, 2007
- Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot projectNature, 2007
- Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivoProceedings of the National Academy of Sciences, 2006
- Modulating Target Site Selection During Human Immunodeficiency Virus DNA IntegrationIn Vitrowith an Engineered Tethering FactorHuman Gene Therapy, 2006
- Gene targeting in vivo by adeno-associated virus vectorsNature Biotechnology, 2006
- Therapeutic gene causing lymphomaNature, 2006
- Gene targeting using zinc finger nucleasesNature Biotechnology, 2005
- Gene Targeting in Stem Cells from Individuals with Osteogenesis ImperfectaScience, 2004
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003
- Chimeric Nucleases Stimulate Gene Targeting in Human CellsScience, 2003